CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.60
-0.22 (-2.81%)
Apr 28, 2026, 11:24 AM EDT - Market open
CorMedix Employees
CorMedix had 191 employees as of December 31, 2025. The number of employees increased by 126 or 193.85% compared to the previous year.
Employees
191
Change (1Y)
126
Growth (1Y)
193.85%
Revenue / Employee
$1,631,984
Profits / Employee
$848,518
Market Cap
596.05M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 191 | 126 | 193.85% | 191 | 0 |
| Dec 31, 2024 | 65 | -18 | -21.69% | 64 | 1 |
| Dec 31, 2023 | 83 | 42 | 102.44% | 82 | 1 |
| Dec 31, 2022 | 41 | 11 | 36.67% | 40 | 1 |
| Dec 31, 2021 | 30 | -5 | -14.29% | 29 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 231 |
| Rigel Pharmaceuticals | 174 |
| Prime Medicine | 146 |
| Sutro Biopharma | 137 |
| Ocugen | 116 |
| Aclaris Therapeutics | 73 |
| Prothena Corporation | 67 |
| Zevra Therapeutics | 61 |
CRMD News
- 22 hours ago - CorMedix Eyes $2 Billion Market With Encouraging Data From Fungal Infection Study - Benzinga
- 1 day ago - CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients - GlobeNewsWire
- 13 days ago - CorMedix Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 21 days ago - CorMedix to Participate in Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - CorMedix Transcript: The Citizens Life Sciences Conference 2026 - Transcripts
- 6 weeks ago - CorMedix Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - CorMedix stock drops after earnings: is this dip a buy before key catalyst? - Invezz
- 7 weeks ago - CorMedix Earnings Call Transcript: Q4 2025 - Transcripts